Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Panacea Life Sciences Hldgs Inc Ordinary Shares EXDI

Healthcare Drug Manufacturers - Specialty & Generic
Exactus, Inc is a healthcare company pursuing opportunities in hemp derived Cannabidiol (CBD) products. The company sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities.


OTCQB:EXDI - Post by User

Panacea Life Sciences Hldgs Inc Ordinary Shares
Bullboard Posts
User Avatar Image
(0)
•••
Post by Ollie07on Aug 14, 2019 6:16pm
83 Views
Post# 30029314

And away we go!!!

And away we go!!!Good earnings today!!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities